SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-002893
Filing Date
2022-02-01
Accepted
2022-02-01 16:58:32
Documents
12
Period of Report
2022-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45657
  Complete submission text file 0001493152-22-002893.txt   218664

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indp-20220201.xsd EX-101.SCH 3039
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indp-20220201_lab.xml EX-101.LAB 34476
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indp-20220201_pre.xml EX-101.PRE 22599
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3498
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 22579666
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences